Proqr Therapeutics (NQ: PRQR )
1.785
-0.015
(-0.83%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 19, 2024
Add to My Watchlist
Headline News about Proqr Therapeutics
![](https://cdn.benzinga.com/files/images/story/2024/01/18/image47_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/11/27/image31_0.jpeg?width=1200&height=800&fit=crop)
US Stocks Lower; Dow Falls Over 50 Points
November 27, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2023/11/08/bluebird_bio_-_logo.jpg?width=1200&height=800&fit=crop)
Bluebird Bio To Rally Around 267%? Here Are 10 Top Analyst Forecasts For Wednesday
November 08, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
4 Analysts Have This to Say About ProQR Therapeutics
August 04, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for ProQR Therapeutics
May 17, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/01/17/image24.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Recap: ProQR Therapeutics Q1 Earnings
May 16, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/30/safe__green_holdings_-_logo.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For ProQR Therapeutics
March 28, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/12/aapharma_15.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/11/aapharma_10.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/30/bed_bath__beyond_-__logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/29/image36.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/726381/optometrist-covering-her-patients-eyes-with-an-occluder-during-an-eye-exam.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_10543.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/29/kodiak_sciences_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/29/image34.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/29/image49.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/23/image-tesla4_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/22/image34.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/12/sklz-1600-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2022/10/electric-vehicle-charging-ev-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2020/03/mrna1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/22/image20.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/22/image21.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/22/image20.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/22/prqr_logo_light__4f1694c259509189da1a8fac435f46e0.png?width=1200&height=800&fit=crop)
ProQR Therapeutics Shares Soar As Eli Lilly Expands RNA Collaboration
December 22, 2022
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-washington-statue.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_24907.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.